• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡相关基因 CHAC1 是肾透明细胞癌不良预后的有效指标。

Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma.

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Nursing Department, Wujiang Fifth People's Hospital, Suzhou, China.

出版信息

J Cell Mol Med. 2021 Apr;25(7):3610-3621. doi: 10.1111/jcmm.16458. Epub 2021 Mar 16.

DOI:10.1111/jcmm.16458
PMID:33728749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034464/
Abstract

To evaluate the validity of CHAC1 for predicting the prognosis of kidney renal clear cell carcinoma (KIRC) and to explore its therapeutic potential for KIRC, we conducted several bioinformatic analyses using the sequencing data and clinical information derived from online databases. We found CHAC1 is down-regulated in KIRC samples when compared with normal samples but up-regulated in KIRC samples with relatively higher malignancy and later stages. Univariate cox analysis and multivariate cox regression analysis were conducted and the results revealed up-regulated CHAC1 is an independent risk factor for poor prognosis of KIRC. Further, the nomogram model based on the result of multivariate cox regression analysis was constructed and effectively predicted patients' 1-year, 3-year and 5-year survival respectively. The correlation analyses showed CHAC1 is associated with the immune pathway markers of memory B cell, natural killer cell and type1 T helper cell as well as the checkpoint genes like ADORA2A, CD200, CD44, CD70, HHLA2, NRP1, PDCD1LG2 and TNFRSF18. Furthermore, experiments in vitro indicated CHAC1 could induce cell death in KIRC cell lines but had limited influence on cell migration and cell invasion. In conclusion, CHAC1 is found a valid indicator for poor prognosis of kidney renal clear cell carcinoma.

摘要

为了评估 CHAC1 预测肾透明细胞癌(KIRC)预后的有效性,并探讨其对 KIRC 的治疗潜力,我们使用来自在线数据库的测序数据和临床信息进行了几项生物信息学分析。我们发现,与正常样本相比,CHAC1 在 KIRC 样本中下调,但在恶性程度较高和晚期的 KIRC 样本中上调。进行了单变量 Cox 分析和多变量 Cox 回归分析,结果表明上调的 CHAC1 是 KIRC 预后不良的独立危险因素。此外,还基于多变量 Cox 回归分析的结果构建了列线图模型,并有效地分别预测了患者的 1 年、3 年和 5 年生存率。相关性分析表明,CHAC1 与记忆 B 细胞、自然杀伤细胞和 1 型 T 辅助细胞的免疫途径标志物以及 ADORA2A、CD200、CD44、CD70、HHLA2、NRP1、PDCD1LG2 和 TNFRSF18 等检查点基因相关。此外,体外实验表明,CHAC1 可诱导 KIRC 细胞系死亡,但对细胞迁移和细胞侵袭的影响有限。总之,CHAC1 被发现是肾透明细胞癌预后不良的有效指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/e5c8f7b74e6e/JCMM-25-3610-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/e055a4510ae5/JCMM-25-3610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/bece73da22ab/JCMM-25-3610-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/4ef1cab8147d/JCMM-25-3610-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/1f3a30a35b22/JCMM-25-3610-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/fe34092c0541/JCMM-25-3610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/e5c8f7b74e6e/JCMM-25-3610-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/e055a4510ae5/JCMM-25-3610-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/bece73da22ab/JCMM-25-3610-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/4ef1cab8147d/JCMM-25-3610-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/1f3a30a35b22/JCMM-25-3610-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/fe34092c0541/JCMM-25-3610-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94d/8034464/e5c8f7b74e6e/JCMM-25-3610-g002.jpg

相似文献

1
Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma.铁死亡相关基因 CHAC1 是肾透明细胞癌不良预后的有效指标。
J Cell Mol Med. 2021 Apr;25(7):3610-3621. doi: 10.1111/jcmm.16458. Epub 2021 Mar 16.
2
A nomogram integrating ferroptosis-and immune-related biomarker for prediction of prognosis and diagnosis in kidney renal clear cell carcinoma.铁死亡和免疫相关生物标志物联合列线图预测肾透明细胞癌预后和诊断。
Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6176-6186. doi: 10.26355/eurrev_202209_29634.
3
Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.肾透明细胞癌中免疫铁死亡基因的综合分析:预后及对肿瘤微环境的影响
Am J Transl Res. 2022 Sep 15;14(9):5982-6010. eCollection 2022.
4
Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.鉴定和验证与香烟烟雾相关的五个基因特征作为肾透明细胞癌的预后生物标志物。
Sci Rep. 2022 Feb 9;12(1):2189. doi: 10.1038/s41598-022-06352-y.
5
COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.COLGAIT1 是预测肾透明细胞癌预后和免疫反应的潜在生物标志物及其 ceRNA 网络的机制。
Eur J Med Res. 2022 Jul 16;27(1):122. doi: 10.1186/s40001-022-00745-5.
6
An Investigation of SPC24 as a Putative Biomarker of Kidney Renal Clear Cell Carcinoma and Kidney Renal Papillary Cell Carcinoma for Predicting Prognosis and/or Immune Infiltration.SPC24 作为肾透明细胞癌和肾乳头状细胞癌的潜在生物标志物用于预测预后和/或免疫浸润的研究。
Comb Chem High Throughput Screen. 2022;25(13):2278-2294. doi: 10.2174/1386207325666220315105054.
7
Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma.全面分析铁死亡和免疫相关特征,以改善肾透明细胞癌的预后和诊断。
Front Immunol. 2022 May 10;13:851312. doi: 10.3389/fimmu.2022.851312. eCollection 2022.
8
Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.LOX 家族基因在肾透明细胞癌中的表达水平及预后价值的综合分析。
Cancer Med. 2020 Nov;9(22):8624-8638. doi: 10.1002/cam4.3472. Epub 2020 Sep 24.
9
Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.基于生物信息学分析和实验验证的上调转录因子 PITX1 预测肾透明细胞癌预后不良。
Dis Markers. 2021 Nov 23;2021:7694239. doi: 10.1155/2021/7694239. eCollection 2021.
10
GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.GRAMD1A 是肾透明细胞癌的生物标志物,与肿瘤微环境中的免疫浸润有关。
Dis Markers. 2022 Jul 11;2022:5939021. doi: 10.1155/2022/5939021. eCollection 2022.

引用本文的文献

1
CHAC1 in urological tumors: contextual dualism and therapeutic implications.泌尿系统肿瘤中的CHAC1:情境二元论及治疗意义
Front Oncol. 2025 Aug 8;15:1610915. doi: 10.3389/fonc.2025.1610915. eCollection 2025.
2
A systematical review on traditional Chinese medicine treating chronic diseases via regulating ferroptosis from the perspective of experimental evidence and clinical application.从实验证据和临床应用角度对中医药通过调控铁死亡治疗慢性病的系统评价。
Chin Herb Med. 2025 Jan 21;17(2):246-260. doi: 10.1016/j.chmed.2025.01.003. eCollection 2025 Apr.
3
CNPY2 Aggravates Renal Tubular Cell Ferroptosis in Diabetic Nephropathy by Regulating PERK/ATF4/CHAC1 Pathway and MAM Integrity.

本文引用的文献

1
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.基于铁死亡相关基因的新型生存模型用于预测透明细胞肾细胞癌的预后。
Aging (Albany NY). 2020 Jul 20;12(14):14933-14948. doi: 10.18632/aging.103553.
2
Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.YIF1B 在泛癌中的预后和免疫调节作用:生存和治疗反应评估的潜在靶点。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20201384.
3
Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study.
CNPY2通过调节PERK/ATF4/CHAC1通路和线粒体相关内质网膜(MAM)完整性加重糖尿病肾病中的肾小管细胞铁死亡。
Adv Sci (Weinh). 2025 Jul;12(25):e2416441. doi: 10.1002/advs.202416441. Epub 2025 Apr 11.
4
Combined transcriptome and metabolome analysis of stable knockdown and overexpression of the CD8A gene in chicken T lymphocytes.鸡T淋巴细胞中CD8A基因稳定敲低和过表达的转录组与代谢组联合分析
Poult Sci. 2025 Feb;104(2):104686. doi: 10.1016/j.psj.2024.104686. Epub 2024 Dec 17.
5
Hsa_circ_0072732 enhances sunitinib resistance of renal cell carcinoma by inhibiting ferroptosis.Hsa_circ_0072732通过抑制铁死亡增强肾细胞癌对舒尼替尼的耐药性。
Discov Oncol. 2024 Nov 23;15(1):700. doi: 10.1007/s12672-024-01580-2.
6
Ferroptosis: insight into the treatment of hepatocellular carcinoma.铁死亡:肝细胞癌治疗新见解
Cancer Cell Int. 2024 Nov 13;24(1):376. doi: 10.1186/s12935-024-03559-z.
7
CHAC1: a master regulator of oxidative stress and ferroptosis in human diseases and cancers.CHAC1:人类疾病和癌症中氧化应激和铁死亡的主要调节因子。
Front Cell Dev Biol. 2024 Oct 29;12:1458716. doi: 10.3389/fcell.2024.1458716. eCollection 2024.
8
CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation.CHAC1 阻断通过劫持 PKM2 核转位干扰葡萄糖代谢来抑制肺腺癌的进展。
Cell Death Dis. 2024 Oct 5;15(10):728. doi: 10.1038/s41419-024-07114-6.
9
Prognostic Values of Ferroptosis-Related Proteins ACSL4, SLC7A11, and CHAC1 in Cholangiocarcinoma.铁死亡相关蛋白ACSL4、SLC7A11和CHAC1在胆管癌中的预后价值
Biomedicines. 2024 Sep 13;12(9):2091. doi: 10.3390/biomedicines12092091.
10
Glutathione‑degrading enzymes in the complex landscape of tumors (Review).肿瘤中谷胱甘肽降解酶的复杂格局(综述)。
Int J Oncol. 2024 Jul;65(1). doi: 10.3892/ijo.2024.5660. Epub 2024 Jun 7.
围手术期口服碳水化合物对乳腺癌患者代谢的影响——一项探索性研究。
BMC Cancer. 2019 Dec 4;19(1):1183. doi: 10.1186/s12885-019-6393-7.
4
Ferroptosis and kidney diseases.铁死亡与肾脏疾病。
Int Urol Nephrol. 2020 Mar;52(3):497-503. doi: 10.1007/s11255-019-02335-7. Epub 2019 Nov 25.
5
Active mixture of serum-circulating small molecules selectively inhibits proliferation and triggers apoptosis in cancer cells via induction of ER stress.活性血清循环小分子混合物通过诱导内质网应激选择性抑制癌细胞增殖并触发细胞凋亡。
Cell Signal. 2020 Jan;65:109426. doi: 10.1016/j.cellsig.2019.109426. Epub 2019 Nov 7.
6
Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.青蒿琥酯激活 ATF4-CHOP-CHAC1 通路并影响伯基特淋巴瘤中的铁死亡。
Biochem Biophys Res Commun. 2019 Nov 12;519(3):533-539. doi: 10.1016/j.bbrc.2019.09.023. Epub 2019 Sep 16.
7
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies.谷胱甘肽代谢在肾细胞癌进展中的作用及其治疗意义。
Int J Mol Sci. 2019 Jul 26;20(15):3672. doi: 10.3390/ijms20153672.
8
Higher expression of cation transport regulator-like protein 1 (CHAC1) predicts of poor outcomes in uveal melanoma (UM) patients.阳离子转运调节因子样蛋白1(CHAC1)的高表达预示葡萄膜黑色素瘤(UM)患者预后不良。
Int Ophthalmol. 2019 Dec;39(12):2825-2832. doi: 10.1007/s10792-019-01129-1. Epub 2019 Jun 3.
9
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.欧洲癌症发病率和死亡率模式:2018 年 40 个国家和 25 种主要癌症的估计值。
Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9.
10
Glutathione in Ovarian Cancer: A Double-Edged Sword.谷胱甘肽在卵巢癌中的作用:一把双刃剑。
Int J Mol Sci. 2018 Jun 26;19(7):1882. doi: 10.3390/ijms19071882.